Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bayer
Age
14–29
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Severe hemophilia A (\<2%)
For subjects who elect staying on Prophylaxis only: Have been on continuous prophylactic treatment for the past 5 years prior to study entry
For subjects who elect switching to on-demand only: Have been on continuous prophylactic treatment for the past 5 years, but may have been on intermediate or reduced prophylaxis for the 1-12 months prior to study entry
For subjects currently on-demand: a retrospective arm of subjects who have been on continuous prophylactic treatment for at least 5 years and switched to on-demand treatment between 13 and 24 months prior to study entry
Current treatment with rFVIII
You may not be if
Other known hematological / bleeding disorders other than hemophilia A
Participating on another study that may have an impact on bleeding or the objectives of this study
Known alcohol and drug abuse
Clareo Health | Evaluation of the Reasons and Consequences of Bleeding in Late Teens and Early Adulthood Patients With Severe Hemophilia A
